Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
about
Nicotine receptor partial agonists for smoking cessationNicotine receptor partial agonists for smoking cessationNicotine receptor partial agonists for smoking cessationGender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey.Innovations in translational sex and gender-sensitive tobacco researchChronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.Strategies for improving cardiovascular health in women with diabetes mellitus: a review of the evidence.Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brainSex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo.Facilitated Extinction Training to Improve Pharmacotherapy for Smoking Cessation: A Pilot Feasibility Trial.Varenicline for smoking cessation intervention in chronic obstructive pulmonary disease.
P2860
Q24185773-D5185C6C-0339-4250-ADF1-A89149CB9489Q24200322-24059532-7395-4552-97C0-6BFB2D0DFFA2Q24235456-7358061A-C0F3-4642-8D74-84F9A46E262DQ35473845-E8380F6F-9CD3-4F5A-8624-14DE1881F40BQ35784973-D7ADF7F3-1449-4303-99FD-8C87C97A5A02Q36335508-DE079CCA-1A7D-4943-B3FE-21E712BD7335Q36950782-0C185810-0D7C-441A-87D3-A134432EEC9AQ37722609-F4297E15-0A1C-4F9F-B597-3C400CD15FB7Q40456297-8A2F116B-74DD-4CF3-A741-A9C356BA5A2FQ43651734-BCC59EA9-2293-408B-80D6-708BBBD646D7Q47773172-B6081024-A776-4FCF-95E9-33805D8A3C44Q50069136-09F73BD9-189A-46E6-90F5-E60A7E5288FFQ52299211-179A368C-C456-4DD9-B640-374D84029F38
P2860
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@ast
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@en
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@nl
type
label
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@ast
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@en
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@nl
prefLabel
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@ast
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@en
Immediate versus delayed quitt ...... line, bupropion SR or placebo.
@nl
P2093
P2860
P1433
P1476
Immediate versus delayed quitt ...... cline, bupropion SR or placebo
@en
P2093
Carmen Arteaga
Douglas E Jorenby
Theodore C Lee
Thomas H Brandon
P2860
P304
P356
10.1111/J.1360-0443.2010.03058.X
P407
P577
2010-09-01T00:00:00Z